Idorsia (XSWX:IDIA) Price-to-Tangible-Book: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:IDIA Idorsia Ltd XSWX:IDIA
48 GF Score
Price CHF4.80
GF Value CHF2.45
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Idorsia Price-to-Tangible-Book?

As of today (2026-09-22), Idorsia's share price is CHF4.796. Idorsia's Tangible Book per Share of Jun. 2026 for the quarter that ended in Jun. 2026 was CHF-4.66. Hence, Idorsia's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Idorsia's Price-to-Tangible-Book or its related term are showing as below:

During the past 10 years, Idorsia's highest Price to Tangible Book Ratio was 58.51. The lowest was 2.88. And the median was 7.26.

XSWX:IDIA's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 3.31
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Idorsia's share price is CHF4.796. Idorsia's Book Value per Sharefor the quarter that ended in Jun. 2026 was CHF-4.54. Hence, Idorsia's P/B Ratio of today is .

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Idorsia Price-to-Tangible-Book Related Terms

Idorsia Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Idorsia's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Idorsia Price-to-Tangible-Book Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.65 - - - -

Idorsia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

XSWX:IDIA vs VRTX, REGN, MRNA: Price-to-Tangible-Book Comparison

For the Biotechnology subindustry, Idorsia's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Idorsia Price-to-Tangible-Book vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Idorsia's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Idorsia's Price-to-Tangible-Book falls into.


XSWX:IDIA
48GF Score
Idorsia Ltd XSWX:IDIA
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Idorsia Price-to-Tangible-Book Calculation

Idorsia's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2026 )
=4.796/-4.656
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Idorsia (XSWX:IDIA) Overvalued in 2026?

Based on GuruFocus' analysis, Idorsia stock appears to be overvalued. The current stock price of CHF4.80 is trading 95.8% above its estimated GF Value™ of CHF2.45. GuruFocus considers Idorsia to be Significantly Overvalued.

Key valuation signals for XSWX:IDIA:

  • Price-to-Tangible-Book:
  • GF Value™: CHF2.45 vs. price of CHF4.80 (95.8% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the XSWX:IDIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Idorsia Business Description

Address Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. The company is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. The company's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
48GF Score

Get the complete analysis for XSWX:IDIA

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF4.80
Price
CHF2.45
GF Value